grant PAR-25-156

RC2 High-Impact Specialized Innovation Programs for CTSA UM1 Hubs (Clinical Trials Optional)

Limited-competition NOFO to fund High-Impact Specialized Innovation Programs (SIPs) at existing CTSA UM1 hubs using the RC2 mechanism to create resources, platforms, and methods that accelerate clinical and translational science. Projects may be disease-agnostic and target areas such as digital health, decentralized/pragmatic trials, AI/ML, data science, real-world evidence, innovative trial d…

The development and implementation of clinical interventions is a complex, iterative, and time-consuming process that takes years before discoveries in biomedical research result in health benefits for patients and communities. The National Center for Advancing Translational Sciences (NCATS) has…

Funding Source

Agency: National Center for Advancing Translational Sciences
Sub-agency: National Institutes of Health

Awards & funding

Eligibility

CTSA Program UM1 hub prime institutions (PAR-24-272) — applicant organizations or active award recipients; only the primary UM1 hub organization may apply (not partner/collaborator institutions)

Limited competition. Eligibility is restricted to CTSA Program UM1 hub prime institutions associated with PAR-24-272 (UM1 Clinical Trial Optional). Only the primary UM1 CTSA program hub organization may apply; partner or collaborator institutions are not eligible to apply as the primary applican…

Dates

Opportunity Released: December 10, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.